
CD30 positive systemic anaplastic large cell lymphoma program in Pharmaceutical Benefits Scheme (PBS) 012-18051139

-   Background
-   Process
-   Resources

[Expand/Collapse all sections]Expand all

CD30 positive systemic anaplastic large cell lymphoma restriction and item codes

Do not share this attachment externally. See Freedom of Information -
Information Publication Scheme.
[\\INTERNAL.DEPT.LOCAL\Shared\NAT\SERDELEXCEL\WORKPRODIMP\Operation
Blueprint Migration\RDT Release
Icons\32w\icon-hidden-attachment.png]CD30 positive systemic anaplastic
large cell lymphoma (sALCL) restriction and item codes

Contact details

PBS Complex Drugs Programs team

Forms

CD30 positive systemic anaplastic large cell lymphoma - brentuximab
vedotin initial authority application (PB123)

Services Australia website

Lymphoma - systemic anaplastic large cell lymphoma

External websites

PBS schedule for CD30 positive systemic anaplastic large cell lymphoma

                                   

-   Services Australia ABN 90 794 605 008 
